SELLAS Life Sciences Group (SLS) Payables: 2011-2024
Historic Payables for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $4.5 million.
- SELLAS Life Sciences Group's Payables rose 4.77% to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $23.9 million, marking a year-over-year increase of 64.65%. This contributed to the annual value of $5.6 million for FY2023, which is 67.98% up from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences Group's Payables is $4.5 million, which was down 28.18% from $6.3 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Payables registered a high of $7.4 million during Q1 2024, and its lowest value of $1.8 million during Q3 2020.
- In the last 3 years, SELLAS Life Sciences Group's Payables had a median value of $3.7 million in 2023 and averaged $4.3 million.
- Its Payables has fluctuated over the past 5 years, first crashed by 53.96% in 2021, then soared by 139.01% in 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Payables (Quarterly) stood at $4.7 million in 2020, then slumped by 53.96% to $2.1 million in 2021, then skyrocketed by 56.58% to $3.4 million in 2022, then spiked by 67.98% to $5.6 million in 2023, then rose by 4.77% to $4.5 million in 2024.
- Its Payables was $4.5 million in Q3 2024, compared to $6.3 million in Q2 2024 and $7.4 million in Q1 2024.